Double blinded randomized placebo controlled trial to examine if intake of 5-aminolevulinic acid supplement can improve clinical symptoms of individuals with Autism Spectrum Disorder
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Aminolevulinic acid/sodium ferrous citrate (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 02 Nov 2021 Status changed from recruiting to completed.
- 08 Apr 2021 New trial record